These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3595704)

  • 1. Verapamil-induced changes in digoxin kinetics in cirrhosis.
    Maragno I; Gianotti C; Tropeano PF; Rodighiero V; Gaion RM; Paleari C; Prandoni R; Menozzi L
    Eur J Clin Pharmacol; 1987; 32(3):309-11. PubMed ID: 3595704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Pedersen KK
    Eur J Clin Pharmacol; 1982; 22(2):123-7. PubMed ID: 7094982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of verapamil on serum digoxin concentration.
    Klein HO; Lang R; Weiss E; Di Segni E; Libhaber C; Guerrero J; Kaplinsky E
    Circulation; 1982 May; 65(5):998-1003. PubMed ID: 7074765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration.
    Pedersen KE; Christiansen BD; Kjaer K; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1983 Jul; 34(1):8-13. PubMed ID: 6861442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.
    Johnson BF; Wilson J; Marwaha R; Hoch K; Johnson J
    Clin Pharmacol Ther; 1987 Jul; 42(1):66-71. PubMed ID: 2954736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of calcium antagonists on plasma digoxin concentration.
    Pedersen KE
    Acta Med Scand Suppl; 1984; 681():31-6. PubMed ID: 6587754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics.
    Rodin SM; Johnson BF; Wilson J; Ritchie P; Johnson J
    Clin Pharmacol Ther; 1988 Jun; 43(6):668-72. PubMed ID: 2967742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
    Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of verapamil on the plasma level of digoxin in man].
    Merola P; Badin A; Paleari DC; De Petris A; Maragno I
    Cardiologia; 1982; 27(7):683-7. PubMed ID: 6892446
    [No Abstract]   [Full Text] [Related]  

  • 12. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
    DiPiro JT; Cote JR; DiPiro CR; Bustrack JA
    Am J Hosp Pharm; 1980 Nov; 37(11):1518-21. PubMed ID: 7211855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicorandil and verapamil, antianginal agents, on plasma digoxin concentrations in rats and dogs.
    Hinohara Y; Yamazaki T; Kuromaru O; Homma N; Sakai K
    J Pharm Pharmacol; 1987 Jul; 39(7):512-6. PubMed ID: 2886618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
    Doering W
    Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.
    Hedman A; Angelin B; Arvidsson A; Beck O; Dahlqvist R; Nilsson B; Olsson M; Schenck-Gustafsson K
    Clin Pharmacol Ther; 1991 Mar; 49(3):256-62. PubMed ID: 2007320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of verapamil.
    Hamann SR; Blouin RA; McAllister RG
    Clin Pharmacokinet; 1984; 9(1):26-41. PubMed ID: 6362951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.
    Pedersen KE; Thayssen P; Klitgaard NA; Christiansen BD; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 25(2):199-206. PubMed ID: 6628501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue levels of digoxin in the rat following pretreatment with verapamil.
    Weinhouse E; Kaplanski J; Genchik G
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):469-72. PubMed ID: 3992024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil-digoxin interaction in chronic hemodialysis patients.
    Rendtorff C; Johannessen AC; Halck S; Klitgaard NA
    Scand J Urol Nephrol; 1990; 24(2):137-9. PubMed ID: 2356453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil and digoxin: interactions in the rat.
    Kaplanski J; Weinhouse E; Topaz M; Genchik G
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):377-88. PubMed ID: 6665298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.